Identification and characterization of wolframin, the product of the wolfram syndrome gene (WFS1), as a novel calmodulin-binding protein.

To search for calmodulin (CaM) targets, we performed affinity chromatography purification of a rat brain extract using CaM fused with GST as the affinity ligand. Proteomic analysis was then carried out to identify CaM-binding proteins. In addition to identifying 36 known CaM-binding proteins, including CaM kinases, calcineurin, nNOS, the IP(3) receptor, and Ca(2+)-ATPase, we identified an ER transmembrane protein, wolframin [the product of the Wolfram syndrome gene (WFS1)] as interacting. A CaM overlay and an immunoprecipitation assay revealed that wolframin is capable of binding the Ca(2+)/CaM complex in vitro and in transfected cells. Surface plasmon resonance analysis and zero-length cross-linking showed that the N-terminal cytoplasmic domain (residues 2-285) of wolframin binds to an equimolar unit of CaM in a Ca(2+)-dependent manner with a K(D) for CaM of 0.15 muM. Various truncation and deletion mutants showed that the Ca(2+)/CaM binding region in wolframin is located from Glu90 to Trp186. Furthermore, we demonstrated that three mutations (Ala127Thr, Ala134Thr, and Arg178Pro) associated with Wolfram syndrome completely abolished CaM binding of wolframin. This observation may indicate that CaM binding is important for wolframin function and that impairment of this interaction by mutation contributes to the pathology seen in Wolfram syndrome.

[1]  Alcino J. Silva,et al.  Calmodulin-Kinases: Modulators of Neuronal Development and Plasticity , 2008, Neuron.

[2]  J. Zenteno,et al.  Familial Wolfram syndrome due to compound heterozygosity for two novel WFS1 mutations , 2008, Molecular vision.

[3]  M. Waxham,et al.  Ca2+/Calmodulin-dependent Protein Kinases , 2008, Cellular and Molecular Life Sciences.

[4]  Tatsuro Hamada,et al.  Proteome analysis of pitcher fluid of the carnivorous plant Nepenthes alata. , 2008, Journal of proteome research.

[5]  H. Katagiri,et al.  WFS1 protein modulates the free Ca2+ concentration in the endoplasmic reticulum , 2006, FEBS letters.

[6]  J. Foskett,et al.  CIB1, a Ubiquitously Expressed Ca2+-binding Protein Ligand of the InsP3 Receptor Ca2+ Release Channel* , 2006, Journal of Biological Chemistry.

[7]  V. Nunes,et al.  Wolfram/DIDMOAD syndrome, a heterogenic and molecularly complex neurodegenerative disease. , 2006, Pediatric endocrinology reviews : PER.

[8]  O. Olsson,et al.  140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry. , 2006, Journal of proteome research.

[9]  T. Rosenberg,et al.  Mutation analysis of the WFS1 gene in seven Danish Wolfram syndrome families; four new mutations identified , 2005, European Journal of Human Genetics.

[10]  D. Storm,et al.  The role of calmodulin as a signal integrator for synaptic plasticity , 2005, Nature Reviews Neuroscience.

[11]  F. Giuliano,et al.  Wolfram syndrome in French population: Characterization of novel mutations and polymorphisms in the WFS1 gene , 2005, Human mutation.

[12]  H. Tokumitsu,et al.  Mechanism of the Generation of Autonomous Activity of Ca2+/Calmodulin-dependent Protein Kinase IV* , 2004, Journal of Biological Chemistry.

[13]  L. Huang,et al.  Ca 2 calmodulin-dependent protein kinase II potentiates ATP responses by promoting trafficking of P 2 X receptors , 2004 .

[14]  M. Permutt,et al.  Wolframin Expression Induces Novel Ion Channel Activity in Endoplasmic Reticulum Membranes and Increases Intracellular Calcium* , 2003, Journal of Biological Chemistry.

[15]  C. Cremers,et al.  Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease , 2003, Human mutation.

[16]  K. Gerbitz,et al.  Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. , 2003, Human molecular genetics.

[17]  C. Cremers,et al.  Molecular characterization of WFS1 in patients with Wolfram syndrome. , 2003, The Journal of molecular diagnostics : JMD.

[18]  D. Storm,et al.  Calmodulin-regulated adenylyl cyclases: cross-talk and plasticity in the central nervous system. , 2003, Molecular pharmacology.

[19]  Y. Oka,et al.  The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells , 2003, Histochemistry and Cell Biology.

[20]  F. Khanim,et al.  WFS1/wolframin mutations, Wolfram syndrome, and associated diseases , 2001, Human mutation.

[21]  R. Lorini,et al.  Identification of novel WFS1 mutations in Italian children with Wolfram syndrome , 2001, Human mutation.

[22]  Yoshifumi Watanabe,et al.  WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. , 2001, Human molecular genetics.

[23]  Yoshifumi Watanabe,et al.  WFS 1 ( Wolfram syndrome 1 ) gene product : predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain , 2001 .

[24]  X. Estivill,et al.  Presence of a major WFS1 mutation in Spanish Wolfram syndrome pedigrees. , 2001, Molecular genetics and metabolism.

[25]  M. Berridge,et al.  The versatility and universality of calcium signalling , 2000, Nature Reviews Molecular Cell Biology.

[26]  C. Klee,et al.  Calcineurin: from structure to function. , 2000, Current topics in cellular regulation.

[27]  D. Collier,et al.  Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. , 1999, American journal of human genetics.

[28]  Masaya Orita,et al.  A novel target recognition revealed by calmodulin in complex with Ca2+-calmodulin-dependent kinase kinase , 1999, Nature Structural Biology.

[29]  Teiichi Furuichi,et al.  Calmodulin Mediates Calcium-Dependent Inactivation of the Cerebellar Type 1 Inositol 1,4,5-Trisphosphate Receptor , 1999, Neuron.

[30]  T. Meitinger,et al.  Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. , 1998, Human molecular genetics.

[31]  P. Behn,et al.  A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome) , 1998, Nature Genetics.

[32]  N. Hayashi,et al.  An expression system of rat calmodulin using T7 phage promoter in Escherichia coli. , 1998, Protein expression and purification.

[33]  L. J. Eldik,et al.  1 – Calmodulin and Calcium Signal Transduction: An Introduction , 1998 .

[34]  T. Barrett,et al.  Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome , 1995, The Lancet.

[35]  F A Quiocho,et al.  Modulation of calmodulin plasticity in molecular recognition on the basis of x-ray structures. , 1993, Science.

[36]  S. Winder,et al.  Calponin-calmodulin interaction: properties and effects on smooth and skeletal muscle actin binding and actomyosin ATPases. , 1993, Biochemistry.

[37]  A. Gronenborn,et al.  Solution structure of a calmodulin-target peptide complex by multidimensional NMR. , 1994, Science.

[38]  F A Quiocho,et al.  Target enzyme recognition by calmodulin: 2.4 A structure of a calmodulin-peptide complex. , 1992, Science.

[39]  H. Jarrett,et al.  Calmodulin specifically binds three proteins of the dystrophin-glycoprotein complex. , 1992, Biochemical and biophysical research communications.

[40]  K. Mikoshiba,et al.  Structural and functional characterization of inositol 1,4,5-trisphosphate receptor channel from mouse cerebellum. , 1991, The Journal of biological chemistry.

[41]  J. Gergely,et al.  Zero-length crosslinking procedure with the use of active esters. , 1990, Analytical biochemistry.

[42]  J. Graff,et al.  Phosphorylation-regulated calmodulin binding to a prominent cellular substrate for protein kinase C. , 1989, The Journal of biological chemistry.

[43]  K. Sobue,et al.  Identification of a new 84/82 kDa calmodulin‐binding protein, which also interacts with actin filaments, tubulin and spectrin, as synapsin I , 1987, FEBS letters.

[44]  K. Gardner,et al.  A new erythrocyte membrane-associated protein with calmodulin binding activity. Identification and purification. , 1986, The Journal of biological chemistry.

[45]  W. Lehman,et al.  Caldesmon is a Ca2+-regulatory component of native smooth-muscle thin filaments. , 1985, The Biochemical journal.

[46]  K. Sobue,et al.  Quantitative determinations of calmodulin in the supernatant and particulate fractions of mammalian tissues. , 1982, Journal of biochemistry.

[47]  T. Vanaman,et al.  Affinity chromatography purification of a cyclic nucleotide phosphodiesterase using immobilized modulator protein, a troponin C-like protein from brain. , 1976, Biochemical and biophysical research communications.

[48]  W. Cheung.  Cyclic 3',5'-nucleotide phosphodiesterase. Evidence for and properties of a protein activator. , 1971, The Journal of biological chemistry.

[49]  H. P. Wagener,et al.  DIABETES MELLITUS AND SIMPLE OPTIC ATROPHY AMONG SIBLINGS: REPORT OF FOUR CASES , 1938 .